tradingkey.logo

Clearpoint Neuro Inc

CLPT

10.530USD

+0.530+5.30%
Fechamento 08/04, 16:00ETCotações atrasadas em 15 min
294.63MValor de mercado
PerdaP/L TTM

Clearpoint Neuro Inc

10.530

+0.530+5.30%
Mais detalhes de Clearpoint Neuro Inc Empresa
ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.
Informações da empresa
Código da empresaCLPT
Nome da EmpresaClearpoint Neuro Inc
Data de listagemJul 03, 2019
CEOMr. Joseph Michael Burnett
Número de funcionários115
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 03
Endereço120 S. Sierra Avenue
CidadeSOLANA BEACH
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal92075
Telefone19499006833
Sitehttps://www.clearpointneuro.com/
Código da empresaCLPT
Data de listagemJul 03, 2019
CEOMr. Joseph Michael Burnett
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.08K
-4.84%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
78.31K
+1.21%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
51.56K
+0.71%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+71.68%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-19.96%
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
Mr. Jeremy L. Stigall
Mr. Jeremy L. Stigall
Chief Business Officer
Chief Business Officer
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.08K
-4.84%
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
78.31K
+1.21%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
51.56K
+0.71%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+71.68%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-19.96%
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Products: Functional neurosurgery
3.28M
38.62%
Services: Biologics and drug delivery
2.91M
34.31%
Products: Biologics and drug delivery
1.78M
20.98%
Services: Capital equipment and other
283.00K
3.34%
Product Systems and software products
234.00K
2.76%
Por RegiãoUSD
Nome
Receita
Proporção
United States
8.48M
100.00%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Products: Functional neurosurgery
3.28M
38.62%
Services: Biologics and drug delivery
2.91M
34.31%
Products: Biologics and drug delivery
1.78M
20.98%
Services: Capital equipment and other
283.00K
3.34%
Product Systems and software products
234.00K
2.76%
Distribuição de ações
Atualizado em: qui, 15 de mai
Atualizado em: qui, 15 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
5.22%
District 2 Capital LP
4.01%
PTC Therapeutics Inc
3.17%
Millennium Management LLC
2.62%
Susquehanna International Group, LLP
1.71%
Other
83.27%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
5.22%
District 2 Capital LP
4.01%
PTC Therapeutics Inc
3.17%
Millennium Management LLC
2.62%
Susquehanna International Group, LLP
1.71%
Other
83.27%
Tipos de investidores
Investidores
Proporção
Investment Advisor
15.28%
Hedge Fund
11.69%
Investment Advisor/Hedge Fund
5.88%
Individual Investor
5.24%
Corporation
3.17%
Research Firm
2.22%
Pension Fund
0.16%
Other
56.37%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
224
12.34M
43.65%
-23.48K
2025Q1
230
12.08M
42.76%
-158.33K
2024Q4
216
11.35M
41.09%
+117.64K
2024Q3
204
10.32M
38.18%
-558.62K
2024Q2
199
10.56M
39.44%
-945.58K
2024Q1
197
10.90M
40.86%
+64.32K
2023Q4
197
9.84M
39.93%
-1.22M
2023Q3
198
9.05M
36.76%
-2.10M
2023Q2
200
8.72M
35.43%
-782.48K
2023Q1
206
7.92M
32.20%
-48.15K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
1.28M
4.54%
+35.59K
+2.85%
Mar 31, 2025
District 2 Capital LP
1.13M
4.01%
+715.76K
+170.85%
Mar 31, 2025
PTC Therapeutics Inc
894.58K
3.17%
--
--
Aug 23, 2024
Millennium Management LLC
741.19K
2.62%
+452.04K
+156.34%
Mar 31, 2025
Susquehanna International Group, LLP
482.37K
1.71%
-26.79K
-5.26%
Mar 31, 2025
Bigger Capital Funds, LP
422.40K
1.49%
-688.79K
-61.99%
Mar 31, 2025
Bigger (Michael)
378.69K
1.34%
+20.00K
+5.58%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
368.02K
1.3%
-174.00
-0.05%
Mar 31, 2025
Brown Advisory
331.10K
1.17%
-2.30K
-0.69%
Mar 31, 2025
Essex Investment Management Company, LLC
327.46K
1.16%
-81.36K
-19.90%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Neuroscience and Healthcare ETF
0.71%
Invesco NASDAQ Future Gen 200 ETF
0.46%
iShares Micro-Cap ETF
0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
Motley Fool Next Index ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Ver Mais
iShares Neuroscience and Healthcare ETF
Proporção0.71%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.46%
iShares Micro-Cap ETF
Proporção0.07%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.06%
Motley Fool Next Index ETF
Proporção0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporção0.02%
iShares Russell 2000 Growth ETF
Proporção0.02%
iShares Russell 2000 ETF
Proporção0.01%
Proshares Ultra Russell 2000
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0.01%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI